The Virtual Regulatory Cross Pharma Event 2021 hosted in collaboration with Janssen saw participation from over 35 pharma regulatory stakeholders representing 10 top pharma logos.
The event, replete with industry relevant themes and discussions, painted a broad picture of pharma regulatory business priorities with technology playing a key role in accelerating it.
Quick snapshot of the Event:
10 industry-mapped sessions
8 pharma logos
35+ registrants and attendees
100+ event interactions
The Regulatory Cross Pharma Event saw speakers from diverse pharma regulatory backgrounds participate in industry-mapped sessions with dynamic and insightful presentations. Key takeaways of the event are shared below.
Dossier Reusability – Leveraging ML and Structured content authoring for a streamlined dossier management
Regulatory Intelligence – Leveraging technology for collection and dissemination of regulatory information
Labeling Operations – Using technology to pivot challenges in labeling operations into opportunities
Regulatory Operations – Smart regulatory insights through regulatory value drivers
Innovation in Regulatory Affairs – Building an enterprise innovation framework by adopting mix of short-term and long-term goals
Intelligent Automation - Enabling digital transformations on Health Authority (HA) query management
Efficiency in HA Interactions – Role of regulatory intelligence in managing various types of communication
Structured Content & Data Management – Managing the ‘Data Clutter’ and extracting relevant information for HAs
Innovation in Labeling Operations – Digital interventions in label intelligence, automation and label knowledge management